secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0000950170-24-130207
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney to acquire two Winston-Salem buildings for $22.5M for rilparencel manufacturing
--------------------------------------------------------------------------------

- Purchase price of $22.5 million in cash for two buildings totaling ~180,000 sq ft.
- Buildings will support manufacturing operations for lead product candidate rilparencel.
- Transaction expected to close by end of November 2024, subject to customary conditions.
- Company currently occupies portions of the buildings under existing leases.
- Agreement contains customary representations; no financing contingency disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024130207/0000950170-24-130207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024130207/prok-20241120.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-130207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer